Nick Norwitz MD PhD Profile picture
Jan 6, 2023 18 tweets 7 min read Read on X
1/18) 🚨NEW PAPER in @AJCN provides evidence supporting #CIM of #obesity

👉 Glycemic Load >>> Calorie Counting for weight loss

👉 Biomarkers of Low carb diet predict weight

👉Insulin hyper-secreters especially benefit fromlow-carb

Video 👉👉
🧵... Image
2/18) First, and foremost, a big congrats to @AdrianSotoMota and @davidludwigmd for an excellent work!

& of course, for those who have the time, I highly recommend reading the full paper, here: doi.org/10.1016/j.ajcn…

But for those who prefer video or TW thread... HERE WE GO...
3/18) What the researchers did in this paper is perform a secondary analysis of pre-existing data from a 12-month RCT: the DIETFITS trial in which 609 adults aged 18-50 without diabetes were randomized to either a 12 m Low-carb diet (LCD) or low-fa diet (LFD).
4/18) Initial data showed LCD led to more weight loss than LFD at 3 and 6 mo, but that the between group diff in weight loss lost significance at 12 months

This was taken to be evidence against the CIM. However, as this paper reveals, there is more nuance to the story... Image
5/18) One important ? is why significance was lost at 12mo?
2 reasons...

i) Participant dropout. Each group lost ~80 participants, diminishing statistic power

AND

ii) Diet convergence: ‘Carb creep’ in the LCD group (132g/d) + carb drop in the LFD group (213g/d) Image
6/18) Even setting aside the dietary convergence, when missing data was imputed, the LCD group did in fact lose more weight at 12 m than the LFD group at all time points. Image
7/18) Moving on, Fig 2 shows a model of predictors of weight loss ➡️ larger circumferences represent better predictors of weight loss

🍽️🍽️Total fat & Calories were poorer predictors of weight loss

🍩🥭Carbs & GI and sugar are the superior predictors

Consistent with the CIM Image
8/18) In Table are 2 models examining the mediators of weight loss

When you add in Glycemic Load (GL) is added to the model in model 2, GL is highly significant (p=5.7x10-5) and calories (p=0.80) LOSE significance!

Let’s expand on this point... Image
9/18) Many think that LCD works bc it just makes you eat fewer calories, but that it’s actually the drop in calorie intake that’s driving the weight loss. This certainly is a contributing factor but...
10/18) These results show that GL is better than caloric intake at predicting weight loss, which may appear counterintuitive BUT can be made intuitive if you think about the components of Energy balance: Calories in & Calories out...
11/18) The CICO model, when taken in CLINICAL practice, usually focuses on CI because accurately measuring CO accurately is next to impossible (think, NEAT, TEF, body temp, etc.)
12/18) By contrast, if GL influences the hormonal milieu of the body, it dictates NOT ONLY hunger and caloric intake (CI) but also homeostatic mechanisms to maintain energy equilibrium, or tip it one way or another, through CO: NEAT, body temp, etc.
13/18) Simply put, one could actually make the argument that the CIM is actually a superior real-life ‘CICO’ model than the standard cal counting CICO model itself!

LOL If that doesn’t make sense, read ^ again and watch video for completeness
14/18) Other cool data presented in this paper consistent with the results already shared is that, in fig 5, a biomarker of low-carb/GL (TG/HDL) was strongly associated with weight loss whereas a biomarker of fat reduction (LDL+HDL) was not. Image
15/18) Finally, and beautifully, the authors put a bold prediction of the CIM to the test which is that those with higher basal insulin secretion would benefit most for GL reduction. Again, this is b/c in the CIM GL influences insulin to cause fat storage.
16/18) So, if someone naturally is an insulin hyper-secreter, the effect of the model is simply going to be amplified. As a result, those who secrete a lot of insulin probably benefit the most from reducing GL. Is that the case? As it turns out yes!
17/18) Clearly see an interaction b/w GL reduction and basal insulin

As you can see in the back left row, these persons who reduced GL most and were the insulin hyper secreters, lost the most weight! Image
18/18) In summary, this paper provides powerful evidence for two prediction of the CIM: (1) GL > Calories as a predictor of weight loss and (2) insulin hyper secreters benefit most from carb reduction.

Video


Paper
doi.org/10.1016/j.ajcn…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Nick Norwitz MD PhD

Nick Norwitz MD PhD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @nicknorwitz

Jan 20
🚨👉What if a diet that lowered your cholesterol… increased your risk of death? (link at the end)

1/12) That’s what a forgotten a double-blind, randomized controlled trial from the 1970s seemed to show.

It tested whether swapping saturated fats for unsaturated fats would improve heart health.

Results?

The group that lowered their cholesterol... died more often. And the lower their cholesterol went, the higher their risk of death.

And if you think you’ve heard this story before (including a proper assessment of the counterarguments and deeper nuances—you haven’t…)Image
2/12) The Minnesota Coronary Experiment was a randomized controlled trial conducted between 1968 and 1973 that enrolled 9,423 men and women across six mental hospitals and one nursing home.

The power of this approach—though ethically questionable by today’s standards—was that researchers could truly blind and control patients’ diets with remarkable accuracyImage
3/12) The researcher tested whether swapping saturated fat for vegetable oil rich in unsaturated fat would reduce heart disease and death.

Butter was replaced with margarine rich in polyunsaturated fat, leading to a diet much lower in saturated fat and higher in unsaturated fat, particularly linoleic acid.

Compared to the baseline hospital diet:
👉 Linoleic acid intake increased by 288%
👉 Saturated fat intake decreased by 51%
Read 12 tweets
Jan 17
A Nuance Hidden in a Historic Statin Trial (link in 12/12)

1/12) Medicine is supposed to treat individuals, not populations averages. And yet, the imprecision remains, like an intellectual cancer.

So, let’s look back at one of the most pivotal studies in cardiovascular history: the 4S trial, an see what is reveals when we stratify but just two biomarkers: TG and HDL

(And if you think you know where this goes, you're in for at least one plot Twist... 🚭)Image
2/12) According to cardiologists, the 4S trial is widely regarded as the study that launched the statin era.

4S was a randomized, double-blind, placebo-controlled study that enrolled 4,444 participants established coronary heart disease.

Patients were assigned to receive either simvastatin (20–40 mg daily) or a placebo and followed for 5.4 years.

The headline findings were that the statin (simvastatin) significantly reduced overall and cardiovascular mortality.

But there’s another part of the story—
3/12) A follow-up published in Circulation in 2001 reanalyzed 4S participants by their HDL-C and triglyceride (TG) levels as well.

“Lipid Triad” = those with highest quartile of TG + lowest quartile HDL-C

(This pattern is characteristic of insulin resistance and metabolic syndrome.)

“Isolated High LDL” = Those with lowest quartile of TG + highest quartile HDL-C

So how did these groups differ in terms of outcomes?Image
Read 12 tweets
Jan 15
Dr @PeterAttiaMD recently published an article entitled, "Pitting facts against sensationalism regarding the role of LDL cholesterol in ASCVD"

1/9) Peter opens with a quote: “We must admit that our opponents in this argument have a marked advantage over us. They need only a few words to set forth a half-truth; whereas, in order to show that it is a half-truth, we have to resort to long and arid dissertations.” ― Frédéric Bastiat

I could not agree more.

That's the purpose of today's letter... to discuss Where's the Nuance, Really?!

Specifically, where is the nuance on Longevity, Cholesterol and ApoB?

What follows is a teaser for a 25 page, 4000 word "long and arid dissertations" -- linked in 7/9 🔗

Punchline: When talking about deceptive simple messaging and biased narratives, medicine should look in the mirror as well.

Let's begin...Image
2/9) Here's where I want to start: The three dumbest words in medicine are: “Lower is better.”

This refers to lowering LDL cholesterol or ApoB.

It’s medical clickbait—seductive, oversimplified, and deeply devoid of nuance. Image
3/9) But better for what? How much better? And how are we lowering it?

“Better” typically means cardiovascular outcomes only—not brain health, not metabolic health, not overall healthspan or lifespan.

“How much better” matters too. Saving 1 life per 10,000 patients treated vs 1 life per 10 treated are radically different facts in a risk‑benefit calculation—yet both get flattened into “better.”

It’s like comparing getting a double-yolk egg to the birth of your child. Stupid.
Read 9 tweets
Jan 13
“You are going to die young.”

1/8) The first time I heard those six words, they were jarring. I was 23.

The insult that provoked that perceived threat was a single number on a lab report: my LDL cholesterol (LDL-C).

After I started a ketogenic diet (June 1, 2019), my LDL-C more than tripled from 95 mg/dl to 321 mg/dl.

Link at the end...Image
2/8) The logic was straightforward:

If I allowed my LDL-C levels to remain in the stratosphere, I would inevitably develop cardiovascular disease and die of a heart attack—young.

The question is this: Does LDL—or more accurately, ApoB—kill?

It sounds like an easy question. But it isn’t.
3/8) Now, there is controversy about the relationship of ApoB to All-Cause Mortality (ACM), or death by any cause.

Some people note that there’s a J-shaped relationship between ApoB and ACM and read into this that lower ApoB might not necessarily be better. Image
Read 8 tweets
Jan 11
🚨The New Dietary Guidelines Are Internally Inconsistent

1/7) Publicly, RFK Jr. says “we’re ending the war on saturated fat.” The iconic food pyramid has been flipped, with butter and beef now at the top.

But read the actual guidelines, and you’ll find the exact same restriction: saturated fat still capped at 10% of daily calories. No change.

(People may not like this thread or the linked long-form letter. But I'm not here to pander or choose political sides. I'm here to seek the clarifications I know Americans want and to 'tough love' this step in the right direction into a proper leap...)

cc @RobertKennedyJr @HHSGovImage
2/7) How can one recommend:
👉Cooking with butter and tallow
👉Eating full-fat dairy three times a day
👉Prioritizing red meat…

🚨Yet still limit saturated fat to 10% of calories? That’s not an opinion. The math doesn’t math?!

Full Breakdown: staycuriousmetabolism.substack.com/p/the-new-diet…
3/7) Other surprises you might have missed:

The sodium cap? Still 2,300 mg/day.

There's still a minimum serving of whole grains

Yes, there are changes. But this isn’t the radical inversion it’s being made out to be. My two cents.

I’m not saying that’s bad. It just is. Image
Read 7 tweets
Jan 10
1/10) No word yet from 'Dr' Johnson. So, I've decided to use this as a springboard to deeper learning.

Quick review: in a recent Twitter exchange between @chamath and @bryan_johnson, Bryan proclaimed: “Definitely do not stop statins.”

Today, we deconstruct common logical missteps that could lead to this misguided medical mandate.

A 🔗 to the full letter is at the end.

This won't be shallow reaction content, but an opportunity to dive deep...Image
2/10) Main Point #1: Causality is Overrated

Just because a molecule or biomarker plays a causal role in a disease process does not mean it is sufficient to cause disease.

More importantly, it does not mean intervention is the prudent path.

The presence of a “causal” variable does not ensure disease nor is the treatment benign.Image
3/10) Let me emphasize the point with an intentionally absurd analogy.

A penis is part of the causal pathway by which a biological male contracts a sexually transmitted disease. Amputation of the causal variable will reduce STD risk.

But in this case, as with the case of LDL cholesterol, presence of the causal variable does not ensure disease nor is the treatment benign.
Read 10 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(